ID: ALA4547598

Max Phase: Preclinical

Molecular Formula: C18H13ClN6S2

Molecular Weight: 412.93

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Nc1nc(Nc2nc(-c3ccc(Cl)cc3)cs2)nc(Sc2ccccc2)n1

Standard InChI:  InChI=1S/C18H13ClN6S2/c19-12-8-6-11(7-9-12)14-10-26-17(21-14)24-16-22-15(20)23-18(25-16)27-13-4-2-1-3-5-13/h1-10H,(H3,20,21,22,23,24,25)

Standard InChI Key:  ZBPKGMZVCSDSMN-UHFFFAOYSA-N

Associated Targets(non-human)

Lacticaseibacillus casei 578 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 412.93Molecular Weight (Monoisotopic): 412.0332AlogP: 5.13#Rotatable Bonds: 5
Polar Surface Area: 89.61Molecular Species: ACIDHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 5.74CX Basic pKa: 4.65CX LogP: 6.42CX LogD: 5.31
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.47Np Likeness Score: -2.02

References

1. Liu H, Long S, Rakesh KP, Zha GF..  (2020)  Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents.,  185  [PMID:31675510] [10.1016/j.ejmech.2019.111804]

Source